Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_provenance.
- NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_assertion description "[At multivariate analysis, only hyperhomocysteinemia (OR 11, 95% CI 3.6-36.2; p < 0.0001) and elevated PAI-1 levels (OR 8.9, 95% CI 3.5-41.3; p < 0.01), in addition to hypertension (OR 40.5, 95% CI 8.6-188.8; p < 0.00001) and hypercholesterolemia (OR 3.1, 95% CI 1.6-20.5; p < 0.05), were independent risk factors for CRVO.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_provenance.
- NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_assertion evidence source_evidence_literature NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_provenance.
- NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_assertion SIO_000772 11583306 NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_provenance.
- NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_assertion wasDerivedFrom befree-20150227 NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_provenance.
- NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_assertion wasGeneratedBy ECO_0000203 NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP606862.RAhrN-A1izls61w4QO9cvTE4XNQEpTIwGtT6gACgIT6HA130_provenance.